Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Nature

Volumn 403, Issue 6769, 2000, Pages 503-511

  Alizadeh, Ash A ^a   Elsen, Michael B ^a,j   Davis, R Eric ^b   Ma, Ch L ^b   Lossos, Izidore S ^a   Rosenwald, Andreas ^c   Boldrick, Jennifer C ^a   Sabet, Hajeer ^b   Tran, True ^b   Yu, Xin ^b   Powell, John I ^c   Yang, Liming ^c   Marü, Gerald E ^d   Moore, Troy ^e   Hudson Jr , James ^e   Lu, Lisheng ^a   Lewis, David B ^a   Tibshirani, Robert ^a   Sherlock, Gavin ^j   Chan, Wing C ^h   Greiner, Timothy C ^h   Weisenburger, Dennis D ^h   Armitage, James O ⁱ   Warnke, Roger ^a   Levy, Ronald ^a   Wilson, Wyndham ^b   Grever, Michael R ^f   Byrd, John C ^g   Botstein, David ^j   Brown, Patrick O ^a   Staudt, Louis M ^b   more..

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^e Research Genetics   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B CELL LYMPHOMA; CANCER SURVIVAL; CARCINOGENESIS; DNA DETERMINATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; PHENOTYPE; PRIORITY JOURNAL;

ADULT; B-LYMPHOCYTES; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; TUMOR CELLS, CULTURED;

EID: 0034598746     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35000501     Document Type: Article

References (50)

1. Hodgkin, T. On some morbid appearances of the absorbant glands and spleen. Med. -Chir. Trans. 17, 68-114 (1832).
2. Sternberg, C. Über eine eigenartige unter dem Bilde der Pseudoleukamie verlaufende Tuberculose des lymphatischen Apparates. Heilk 19, 21-90 (1898).
3. Reed, D. M. On the pathological changes in Hodgkins disease, with especial reference to its relation to tuberculosis. Johns Hopkins Hosp. Rep. 10, 133-196 (1902).
4. Rosenberg, S. A. Classification of lymphoid neoplasms. Blood 84, 1359-1360 (1994).
5. Harris, N. L. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84, 1361-1392 (1994).
6. The Non-Hodgkin's Lymphoma Classification Project: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909-3918 (1997).
7. Vose, J. M. Currenl approaches to the management of non-Hodgkin's lymphoma. Semin. Oncol. 25, 483-491 (1998).
8. The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N. Engl. J. Med. 329, 987-994 (1993).
9. Klein, U. et al. Somatic hypermutation in normal and transformed human B cells. Immunol. Rev. 162, 261-280 (1998).
10. Schena, M., Shalon, D., Davis, R. W. & Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995).
11. Bubendorf, L. et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J. Natl Cancer Inst. 91, 1758-1764 (1999).
12. Wang, K. et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 229, 101-108 (1999).
13. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
14. Khan, J. et al. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 58, 5009-5013 (1998).
15. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-217 (1999).
16. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
17. Alon, U. et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl Acad. Sci. USA 96, 6745-6750 (1999).
18. Alizadeh, A. et al. The Lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes. Cold Spring Harbor Symp. Quant. Biol. (in the press).
19. Alizadeh, A., Eisen, M., Botstein, D., Brown, P. O. & Staudt, L. M. Probing lymphocyte biology by genomic-scale gene expression analysis. J. Clin. Immunol. 18, 373-379 (1998).
20. Eisen, M. B., Spellman, P. T., Brown, P. O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95, 14863-14868 (1998).
21. Grogan, T. M. et al. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67, Blood 71, 1157-1160 (1988).
22. Staudt, L. M., Dent, A. L., Shaffer, A. L. & Yu, X. Regulation of lymphocyte cell fate decisions and lymphomagenesis by BCL-6. Int. J. Immunol 18, 381-403 (1999).
23. Bahler, D. W. & Levy, R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl Acad. Sci. USA 89, 6770-6774 (1992).
24. Liu, Y. -J. & Banchereau, J. in Handbook of Experimental Immunology (eds Weir. D., Blackwell, C., Herzenberg, L. & Herzenberg, L.) 93.1-93.9 [Blackwell Scientific, Oxford, 1996].
25. Golay, J., Erba, E., Bernasconi, S., Peri, G. & Introna, M. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and slgM-B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol. 153, 543-553 (1994).
26. Kuo, F. C. & Sklan J. Augmented expression of a human gene for 8-oxoguanine DNA glycosylase (MutM) in B lymphocytes of the dark zone in lymph node germinal centers. J. Exp. Med. 186, 1547-1556 (1997).
27. Flenghi, L. et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. Am. J. Pathol. 147, 405-411 (1995).
28. Pittaluga, S. et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J. Pathol. 179, 145-150 (1996).
29. Zani, V. J. et al. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24. 1;q32. 3;q24. 1) in a Boskitt lymphoma cell line defines a new gene (BCL7A] with homology to caldesmon. Blood 87, 3124-3134 (1996).
30. Fukuda, T. et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. J. Exp. Med. 186, 439-448 (1997).
31. Ye, B. H. et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nature Const. 16, 161-170 (1997).
32. Dent, A. L. Shaffer, A. L., Yu, X., Allman, D. & Staudt, L. M. Control of inflammation, cytokine expression, and gectronal center formation by BCL-6. Science 276, 589-592 (1997).
33. Rabbits, T. H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 12, 2651-2657 (1998).
34. Iida, S. et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nature Genet. 17, 226-230 (1997).
35. Matsuyama, T. et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23, 2127-2136 (1995).
36. Mittrucker, H. W. et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 275, 540-543 (1997).
37. Tschopp, J., Irmler, M. & Thome, M. Inhibition of fas death signals by FLIPs. Curr. Opin. Immunol. 10, 552-558 (1998).
38. Djerbi, M. et al. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J. Exp. Med. 190, 1025-1031 (1999).
39. Medema, J. P., de Jong, J., van Hall, T., Melief, C. J. M. & Offringa, R. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein. J. Exp. Med. 190, 1033-1038 (1999).
40. Fisher, R. I. et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N. Engl. J. Med. 328, 1002-1006 (1993).
41. Jalkanen, S., Joensuu, H., Soderstrom, K. O. & Klemi, P. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma, J. Clin. Invest. 87, 1835-1840 (1991).
42. Harada, S. et al. Molecular and immunological dissection of diffuse large B cell lymphoma: CD5-, and CD5-with CD10+ groups may constitute clinically relevant subtypes. Leukemia 13, 1441-1447 (1999).
43. Kramer, M. H. et al. Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. J. Clin. Oncol 14, 2131-2138 (1996).
44. Preti, H. A. et al. Prognostic value of serum interleukin-6 in diffuse large cell lymphoma. Ann. Int. Med. 127, 186-194 (1997).
45. Gascoyne, R. D. et al. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma. Blood 90, 244-251 (1997).
46. Kramer, M. H. et al. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 92, 3152-3162 (1998).
47. Klein, U., Rajewsky, K. & Kuppers, R. Human immunoglobulin (lg)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188, 1679-1689 (1998).
48. Tangye, S. G., Liu, Y. J., Aversa, G., Phillips, J. H. & de Vries, J. E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J. Exp. Med. 188, 1691-1703 (1998).
49. Allman, D. et al. BCL-6 expression during B-cell activation. Blood 87, 5257-5268 (1996).
50. Eisen, M. B. & Brown, P. O. DNA arrays for analysis of gene expression. Methods Enzymol. 303, 179-205 (1999).